Skip to content
Institutional Investor pre-Series A Series A early-stage clinical development Est. 2016

3B FUTURE Health Fund

Early-stage centric Life Sciences-focused venture capital firm investing in geographies such as Europe and the US

📍 Monte Carlo, Monaco

About This Fund

Helsinn Investment Fund is an early-stage focused venture capital investment company. Geographies of interest include Europe and the US. Typically invests in life sciences startups operating in sectors such as Biotech, Diagnostic and Medical Devices. Top investments include GreenBone, OncoResponse, QuantuMDx.

Investment Focus

Sectors
oncology rare diseases
Stages
pre-Series A Series A early-stage clinical development
Check Size up to $12M per company
Geography
USA Israel Europe

What They Look For

US, Europe, Israel-based; first-in-class assets; experienced management teams; strong investor syndicate; high unmet patient needs; solid IP; shares core values of quality, integrity, respect

Preparing to pitch 3B FUTURE Health Fund?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →